Tominaga, A.
Wada, K.
Okazaki, K.
Nishi, H.
Terayama, Y.
Kodama, Y.
Kato, Y.
Article History
Received: 24 May 2021
Accepted: 2 December 2021
First Online: 21 January 2022
Declarations
:
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Tokyo Women’s Medical University Ethics Committee, number 5596.
: Informed consent was obtained from all participants included in the study.
: Not applicable.
: Ayako Tominaga, Ken Okazaki, Hideharu Nishi, Yasushi Terayama, Yasuteru Kodama, and Yoshiharu Kato declare that they have no conflicts of interest. Keiji Wada received a speaking fee from Amgen Inc.